NMRA
USDNeumora Therapeutics Inc. Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$2.560
最高
$2.920
最低
$2.550
交易量
1.60M
公司基本面
市值
480.9M
行業
生物科技
國家
United States
交易統計
平均交易量
1.36M
交易所
NMS
貨幣
USD
52週範圍
相關新聞
Neumora Therapeutics to Participate in Upcoming Conferences in November
WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NASDAQ:NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel
Needham Maintains Buy on Neumora Therapeutics, Raises Price Target to $8
Needham analyst Ami Fadia maintains Neumora Therapeutics with a Buy and raises the price target from $6 to $8.
Guggenheim Upgrades Neumora Therapeutics to Buy, Announces $14 Price Target
Guggenheim analyst Yatin Suneja upgrades Neumora Therapeutics from Neutral to Buy and announces $14 price target.
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model
NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction NMRA-215 demonstrated best-in-class weight loss of up to 26% in combination with semaglutide Class-leading
